ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
New Perspectives on Micronised Purified Flavonoid Fraction in Chronic Venous Disease
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 241480" data-attributes="member: 13851"><p><strong>Key Summary Points</strong></p><p><strong></strong></p><p><strong><em>*Chronic venous disease (CVD) is a progressive condition with a growing global burden associated with population aging and increasing levels of obesity. Micronised purified flavonoid fraction (MPFF), a venoactive drug used to reduce leg pain and functional discomfort, has recently demonstrated beneficial effects on microcirculation in animal models of CVD </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*MPFF was found to simultaneously inhibit leukocyte adhesion and improve venous tone resulting in the restoration of valvular competence and vessel wall protection from inflammation in both animal models and patients with CVD </em></strong></p><p><strong><em></em></strong></p><p><em><strong>*MPFF is strongly recommended by international guidelines on venoactive drug treatment, but further studies are required to assess the impact of early MPFF initiation and long-term treatment on CVD progression</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 241480, member: 13851"] [B]Key Summary Points [I]*Chronic venous disease (CVD) is a progressive condition with a growing global burden associated with population aging and increasing levels of obesity. Micronised purified flavonoid fraction (MPFF), a venoactive drug used to reduce leg pain and functional discomfort, has recently demonstrated beneficial effects on microcirculation in animal models of CVD *MPFF was found to simultaneously inhibit leukocyte adhesion and improve venous tone resulting in the restoration of valvular competence and vessel wall protection from inflammation in both animal models and patients with CVD [/I][/B] [I][B]*MPFF is strongly recommended by international guidelines on venoactive drug treatment, but further studies are required to assess the impact of early MPFF initiation and long-term treatment on CVD progression[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
New Perspectives on Micronised Purified Flavonoid Fraction in Chronic Venous Disease
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top